SS 20 - DEIH 1:

Moderator(s)

• 

  Jason Domogauer, MD, PhD

  NYU Langone Laura and Isaac Perlmutter Cancer Center
  New York, NY, United States
• 

  Melissa Vyfhuis, MD, PhD

  University of Maryland Radiation Oncology
  Largo, MD, United States

Presentations:

• 10:45 AM – 10:55 AM ET

  Transgender and Non-Binary Use of Gender-Affirming Hormone Therapy and Effects on PSA and Prostate Cancer Detection
  

  Presenter: Paul Riviere, MD – UCSD Radiation Medicine and Applied Sciences
• 10:55 AM – 11:05 AM ET

  Centering Black Voices: Factors Influencing a Cancer Patients Decision to Join a Clinical Trial
  

  Presenter: Charlyn Gomez, BS – University of Maryland School of Medicine
• 11:05 AM – 11:15 AM ET

  Identification of a High-Risk Population in the United States for Anti-EBV Serologic Screening for Nasopharyngeal Carcinoma
  

  Presenter: Payton Clark, BS – Cleveland Clinic Foundation
• 11:15 AM – 11:25 AM ET

  Cancer Screening Knowledge and Interest in Incarcerated Women
  

  Presenter: Bradley Eckelmann, MD, PhD – University of Wisconsin Hospitals and Clinics
• 11:25 AM – 11:35 AM ET

  Paid Medical Leave and Mortality Risk in Working Cancer Survivors
  

  Presenter: Abigail Kohut-Jackson, BS, MBS – Saint Louis University School of Medicine
• 11:35 AM – 11:45 AM ET

  Can Radiotherapy Quality Assurance (RT QA) Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries (LMICs) - Technical Results of the Second Phase of a Prospective International Ato
  

  Presenter: June Corry, MD – GenesisCare
• 11:45 AM – 11:55 AM ET

  Discussant
  

  Discussant: Vonetta Williams, MD, PhD – Memorial Sloan Kettering Cancer Center